Lexeo Therapeutics, Inc. - Common stock, par value $0.0001 (LXEO)

CUSIP: 52886X107

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common stock, par value $0.0001
Shares outstanding
73,698,416
Total 13F shares
29,735,114
Share change
+1,722,736
Total reported value
$268,784,046
Price per share
$9.04
Number of holders
67
Value change
+$10,322,355
Number of buys
48
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 52886X107?
CUSIP 52886X107 identifies LXEO - Lexeo Therapeutics, Inc. - Common stock, par value $0.0001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of LXEO - Lexeo Therapeutics, Inc. - Common stock, par value $0.0001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
4.6%
3,369,147
$54,041,118 30 Jun 2024
13F
JANUS HENDERSON GROUP PLC
13F
Company
4.3%
3,163,992
$50,726,379 30 Jun 2024
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
3.5%
2,597,736
$41,667,685 30 Jun 2024
13F
CITADEL ADVISORS LLC
13F
Company
3.5%
2,558,611
$41,040,120 30 Jun 2024
13F
D1 Capital Partners L.P.
13F
Company
3.4%
2,506,607
$40,205,976 30 Jun 2024
13F
Omega Fund Management, LLC
13F
Company
3.2%
2,355,904
$37,788,700 30 Jun 2024
13F
Longitude Capital Partners IV, LLC
3/4/5
10%+ Owner
class O/S missing
2,567,100
$33,933,468 07 Nov 2023
Omega Fund VI, L.P.
3/4/5
10%+ Owner
class O/S missing
2,157,623
$28,520,755 07 Nov 2023
Invest A/s Lundbeckfond
3/4/5
10%+ Owner
class O/S missing
1,835,959
$24,268,808 07 Nov 2023
Novo Holdings A/S
13F
Company
2%
1,450,500
$23,266,020 30 Jun 2024
13F
BRAIDWELL LP
13F
Company
1.9%
1,382,481
$22,174,995 30 Jun 2024
13F
Vestal Point Capital, LP
13F
Company
1.1%
840,000
$13,473,600 30 Jun 2024
13F
Woodline Partners LP
13F
Company
1.1%
824,074
$13,218,147 30 Jun 2024
13F
Blackstone Inc.
13F
Company
1.1%
805,757
$12,924,342 30 Jun 2024
13F
BlackRock Finance, Inc.
13F
Company
1.1%
791,584
$12,697,008 30 Jun 2024
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
0.91%
672,712
$10,790,300 30 Jun 2024
13F
VANGUARD GROUP INC
13F
Company
0.85%
629,919
$10,103,900 30 Jun 2024
13F
Artal Group S.A.
13F
Company
0.82%
603,435
$9,679,097 30 Jun 2024
13F
Laurion Capital Management LP
13F
Company
0.62%
453,582
$7,275,455 30 Jun 2024
13F
Verition Fund Management LLC
13F
Company
0.57%
421,392
$6,759,128 30 Jun 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.4%
296,612
$4,758,158 30 Jun 2024
13F
STATE STREET CORP
13F
Company
0.27%
196,272
$3,148,203 30 Jun 2024
13F
TUDOR INVESTMENT CORP ET AL
13F
Company
0.18%
132,187
$2,120,279 30 Jun 2024
13F
NORTHERN TRUST CORP
13F
Company
0.13%
94,907
$1,522,308 30 Jun 2024
13F
Polar Asset Management Partners Inc.
13F
Company
0.09%
65,300
$1,047,412 30 Jun 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.05%
37,466
$600,955 30 Jun 2024
13F
Bank of New York Mellon Corp
13F
Company
0.04%
31,806
$510,168 30 Jun 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.04%
30,861
$495,010 30 Jun 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.04%
26,853
$430,722 30 Jun 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.04%
26,759
$429,214 30 Jun 2024
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.03%
22,101
$354,500 30 Jun 2024
13F
BARCLAYS PLC
13F
Company
0.03%
19,153
$307,215 30 Jun 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.02%
18,293
$293,420 30 Jun 2024
13F
CAXTON CORP
13F
Company
0.02%
17,851
$286,331 30 Jun 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.02%
14,651
$235,003 30 Jun 2024
13F
Paul McCormac
3/4/5
Chief Technical Officer
class O/S missing
17,349
$229,329 07 Nov 2023
FRANKLIN RESOURCES INC
13F
Company
0.02%
14,035
$225,121 30 Jun 2024
13F
RHUMBLINE ADVISERS
13F
Company
0.02%
13,357
$214,238 30 Jun 2024
13F
MORGAN STANLEY
13F
Company
0.02%
12,663
$203,114 30 Jun 2024
13F
CITIGROUP INC
13F
Company
0.02%
11,545
$185,182 30 Jun 2024
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.01%
10,750
$172,430 30 Jun 2024
13F
MetLife Investment Management, LLC
13F
Company
0.01%
6,420
$102,977 30 Jun 2024
13F
Corebridge Financial, Inc.
13F
Company
0.01%
5,507
$88,332 30 Jun 2024
13F
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
13F
Company
0.01%
4,881
$78,291 30 Jun 2024
13F
DEUTSCHE BANK AG\
13F
Company
0.01%
4,560
$73,142 30 Jun 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.01%
4,363
$69,983 30 Jun 2024
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.01%
4,187
$67,159 30 Jun 2024
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
3,341
$53,590 30 Jun 2024
13F
UBS Group AG
13F
Company
0%
3,129
$50,189 30 Jun 2024
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
1,950
$31,278 30 Jun 2024
13F

Institutional Holders of Lexeo Therapeutics, Inc. - Common stock, par value $0.0001 (LXEO) as of Q3 2024

As of 30 Sep 2024, Lexeo Therapeutics, Inc. - Common stock, par value $0.0001 (LXEO) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 29,735,114 shares. The largest 10 holders included JANUS HENDERSON GROUP PLC, CITADEL ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., D1 Capital Partners L.P., Omega Fund Management, LLC, EVENTIDE ASSET MANAGEMENT, LLC, BlackRock, Inc., Frazier Life Sciences Management, L.P., Blackstone Inc., and Novo Holdings A/S. This page lists 67 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
57
Q3 2024 holders
67
Holder diff
10
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 Value $ Q3 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .